Mice pre-treated with the TLR3 agonist poly(I:C) and the TLR7 agonist, imiquimod, were protected from DSS-induced colitis, whereas mice deficient in both TLR3 and TLR7 were more susceptible to DSS-induced colitis. This evidence concerns the gene TLR7 and colitis.